Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
<0,1
General Information
Version
1.3
Revision date
2022-03-11
Product name
D-Malic Acid Assay Kit (Bottle 1)
1.2.1 Relevant identified uses
Professional use
Manufacturer Name
Megazyme
Emergency telephone
+353 12861220
Icons in SDS
Company Information
company name
Megazyme
e-mail address of the competent person responsible for the Safety Data Sheet
cs@megazyme.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice
Hazard pictograms
GHS07 GHS07
Signal word
Warning Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention.
Supplemental label elements
EUH032 - Contact with acids liberates very toxic gas. Labelling according to: exemption for packages of a capacity of 125ml or less EUH032 - Contact with acids liberates very toxic gas.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 Signal word (CLP) : Warning Hazard statements (CLP) : H319 - Causes serious eye irritation. Precautionary statements (CLP) : P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. EUH-statements : EUH032 - Contact with acids liberates very toxic gas. Labelling according to: exemption for packages of a capacity of 125ml or less Hazard pictograms (CLP) : GHS07 Signal word (CLP) : Warning EUH-statements : EUH032 - Contact with acids liberates very toxic gas. 2.3. Other hazards Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Glycylglycine CAS-No.: 556-50-3 10 – 20 Eye Irrit. 2, H319 EC-No.: 209-127-8 sodium azide CAS-No.: 26628-22-8 < 0,1 Acute Tox. 2 (Oral), H300 substance with a Community workplace exposure limit EC-No.: 247-852-1 Aquatic Acute 1, H400 EC Index-No.: 011-004-00-7 Aquatic Chronic 1, H410 Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures after inhalation : Remove person to fresh air and keep comfortable for breathing. First-aid measures after skin contact : Wash skin with plenty of water. First-aid measures after eye contact : Rinse eyes with water as a precaution. First-aid measures after ingestion : Call a poison center or a doctor if you feel unwell. 4.2. Most important symptoms and effects, both acute and delayed No additional information available 4.3. Indication of any immediate medical attention and special treatment needed Treat symptomatically. SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media : Water spray. Dry powder. Foam. Carbon dioxide. 5.2. Special hazards arising from the substance or mixture Hazardous decomposition products in case of fire : Toxic fumes may be released. 5.3. Advice for firefighters Protection during firefighting : Do not attempt to take action without suitable protective equipment. Self-contained breathing apparatus. Complete protective clothing. SECTION 6: Accidental release measures 6.1. Personal precautions, protective equipment and emergency procedures 6.1.1. For non-emergency personnel Emergency procedures